Home › Funds › CVS HEALTH Corp › JPST
CVS HEALTH Corp position in JPST
J P MORGAN EXCHANGE TRADED F
CVS HEALTH Corp reported holding 98,500 shares of JPST (J P MORGAN EXCHANGE TRADED F) in its Q3 2026 13F filing — a position valued at US$5.0M, representing 1.16% of its reported portfolio and ranking #19 among its reported holdings. CVS HEALTH Corp has disclosed JPST holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How CVS HEALTH Corp's JPST position evolved
CVS HEALTH Corp first disclosed a stake in JPST in Q4 2025 at 98,500 shares (US$5.0M). The position peaked in Q1 2026 at 98,500 shares, worth US$5.0M. Across 4 filings, CVS HEALTH Corp held the position steady without any share-count change. The most recent filing (Q3 2026) shows 98,500 shares valued at US$5.0M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 98.50K | $4.98M | New |
| Q1 2026 | 98.50K | $4.99M | Hold |
| Q2 2026 | 98.50K | $4.98M | Hold |
| Q3 2026 | 98.50K | $4.96M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About JPST and 13F data
JPST (J P MORGAN EXCHANGE TRADED F) is a company whose sector is not yet classified in our data. 32 other funds we track also report a position in JPST — the largest reported positions include JPMorgan Chase & Co (US$4.75B), Betterment LLC (US$695.8M), HB Wealth Management, LLC (US$516.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding JPST
- JPMorgan Chase & Co 94.32M sh · $4.75B · Q3 2026
- Betterment LLC 13.76M sh · $695.75M · Q2 2026
- HB Wealth Management, LLC 10.31M sh · $516.67M · Q3 2026
- Temasek Holdings 5.92M sh · $299.35M · Q2 2026
- Temasek Holdings (Private) Ltd 5.92M sh · $298.16M · Q3 2026
- Cerity Partners LLC 5.45M sh · $275.52M · Q2 2026
- FOSTER DYKEMA CABOT & PARTNERS, LLC 4.77M sh · $240.15M · Q3 2026
- WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 3.75M sh · $188.60M · Q3 2026
- RiverFront Investment Group, LLC 2.74M sh · $137.83M · Q3 2026
- Kensington Asset Management, LLC 2.70M sh · $136.59M · Q2 2026
- ADVENTIST HEALTH SYSTEM SUNBELT HEALTHCARE CORP 2.46M sh · $123.66M · Q3 2026
- Cornerstone Management, Inc. 2.39M sh · $120.22M · Q3 2026
More on CVS HEALTH Corp
FAQ
How long has CVS HEALTH Corp held JPST?
CVS HEALTH Corp has disclosed JPST holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is CVS HEALTH Corp's current position in JPST?
As of Q3 2026, CVS HEALTH Corp holds 98.50K shares of JPST (J P MORGAN EXCHANGE TRADED F), valued at $4.96M, representing 1.16% of its reported portfolio and ranking #19.
Has CVS HEALTH Corp been buying or selling JPST?
In the latest 13F filing (Q3 2026), CVS HEALTH Corp held unchanged its position in JPST. The position peaked in Q1 2026 at 98.50K shares.
Which other funds hold JPST?
Other major institutional holders of JPST include JPMorgan Chase & Co, Betterment LLC, HB Wealth Management, LLC, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.